brought to you by the Critical Minerals Institute (CMI). In this edition

Lixte’s Big Bet: Making Other Cancer Drugs Work Harder

Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) is a Nasdaq-listed biotech with an unusually focused story: one main drug,…